8:30 am - 5:00 pm
Lunch will be provided.
Cocktail reception to follow, 5:30 pm - 7:30 pm, Radisson Blu Lakeside Grill.
Hotel accommodations can be made at the Raddison Blu. To receive the group rate, please book your hotel by May 30, 2018. Please use this LINK to book your room.
Complimentary day parking (will get tickets).
$15 overnight parking
Accomodations and hotel details can be found here.
Thursday, June 21st, 2018
9:00 – 9:10 a.m. Welcome, Audrey Davidow Lapidus, President, Pitt Hopkins Research Foundation
9:10 – 9:35 a.m. Epigenetic Approaches to Improving Cognition in Pitt Hopkins Syndrome, Andrew Kennedy, PhD, Assistant Professor, Bates College
10:30 – 10:45 a.m. Questions for Session 1 Talks
10:45 – 11:00 a.m. Break, Coffee and refreshments available
11:00 – 11:25 a.m. Regulation of TCF4 Activity and Characterization of its Target Genes in Neurons, Tõnis Timmusk, PhD, Department of Gene Technology, Tallinn University of Technology
11:25 - 11:50 p.m. Evidence for Myelination Deficits in Pitt Hopkins Syndrome, Brady Maher, PhD, Lieber Institute for Brain Development, Johns Hopkins Medical Campus
11:50 – 12:15 p.m. Gene Therapy for Pitt Hopkins Syndrome, Steven Gray, PhD, Associate Professor, Director, UTSW Viral Vector Facility, University of Texas Southwestern Medical Center
12:20 – 12:35 p.m. Questions for Session 2 Talks
12:35 – 1:30 p.m. Lunch
1:30 – 1:55 p.m. Protein Replacement Therapy for Pitt Hopkins Syndrome, Michelina Iacovino, PhD, Assistant Professor, Los Angeles Biomedical Research Institute
1:55 – 2:20 p.m. In Silico Drug Repurposing in Pitt Hopkins Syndrome, Ian Roberts, PhD, Chief Technology Officer, Healx Ltd.
2:20 – 2:40 p.m. Repurposing for Rare Diseases, Sean Ekins, PhD, PHRF Scientific Advisory Board Member, CEO, Collaborations Pharmaceuticals
2:40 – 2:55 p.m. Questions for Session 3 Talks
2:55 – 3:15 p.m. Break
3:15 – 3:40 p.m. Pharmacological Screening in an In Vivo Pitt Hopkins Model, Daniel Marenda, PhD, Associate Professor, Department of Biology, Drexel University
3:40 – 4:00 p.m. Registry Update, Jessica Fletcher, Vice President, Pitt Hopkins Research Foundation
4:00 – 4:25p.m. Dallas Clinic Update, Kimberly Goodspeed, MD, Pitt Hopkins Clinic, University of Texas Southwestern Medical Center
4:25 – 4:45 p.m. Closing Remarks, Sofia Pauca, Princeton University, Class of 2021, Sabine Kastner Lab, Neuroscience Institute
5:30 – 7:30 p.m. Evening Reception for researchers and board members, Lakeside Grill, cocktail reception
Radisson Blu Mall of America, 2100 Killebrew Drive, Bloomington, MN 55425
Conference site: Embassy Suites by Hilton Bloomington
8:00 – 8:20 a.m. Welcome, Audrey Davidow Lapidus, President, Pitt Hopkins Research Foundation
LAY TALKS & PARENT INFORMATION
8:20 – 8:40 a.m. In Silico Drug Repurposing in Pitt Hopkins Syndrome, Ian Roberts, PhD, Chief Technology Officer, Healx Ltd.
8:45 – 9:15 a.m. Development of New Therapeutics for Neurodevelopmental Disorders at the Vanderbilt Center for Neuroscience Drug Discovery: Focus on PTHS, Colleen Niswender, PhD, and Annah Moore, Graduate Student, Vanderbilt University, Sweatt Lab
9:20 – 9:45 a.m. Your Poop: A New Lens into Disease, Daniel McDonald, PhD, American Gut Project, Rob Knight Lab, UC San Diego
9:50 – 10:05 a.m. Break
10:05 – 10:30 a.m. Gene Therapy in Pitt Hopkins Syndrome, Steven Gray, PhD, University of Texas Southwestern Medical Center
10:35 – 10:55 a.m. Dallas Clinic Update, Sailaja Golla, MD and Kimberly Goodspeed, MD, Pitt Hopkins Clinic, University of Texas Southwestern Medical Center
11:00 – 11:45 p.m. Turning Science into Solutions for Rare CNS Disorders, Robert Ring, PhD, Autó's Consulting & Drexel University
11:45 – 12:45 p.m. Lunch
Parent programing in the afternoon.